Who are Crisprqc's investors?

Crisprqc's investors include BioBrit, Serra Ventures, Suncoast Ventures.

How much funding has Crisprqc raised?

Crisprqc has disclosed $4.8M raised across 2 rounds.

Where is Crisprqc headquartered?

Crisprqc is headquartered in San Diego, US.

Crisprqc

San Diego, US · Founded 2021 · Delaware corporation · 11 employees on LinkedIn · 3 known investors

Find your way into Crisprqc

6 people in our graph share verified history with the Crisprqc team — schools, employers, funds. One of them is your warm intro.

Elia Stupkaunlockedknows Ross Bundy · together at Cardea Bio Inc. (overlapped)

×5knows the team · via Bumble Bee

CRISPR QC develops the CRISPR Analytics Platform, a graphene-based biosensor system that provides real-time quantitative kinetic measurements of RNP formation, DNA target binding, and CRISPR-Cas cleavage activity. It serves gene-editing discovery, development, and manufacturing teams to pre-screen gRNA efficiency and de-risk experiments before costly downstream sequencing and screening.

Biotech Deep Tech Hardware

Founders & leadership

Ross Bundy inChief Executive OfficerRoss Bundy is Chief Executive Officer of Crisprqc, which develops a graphene-based CRISPR biosensor platform for gene-editing applications. He previously co-founded and scaled Cardea Bio Inc. and has over six years of biotechnology experience.

Kiana AranNamed on SEC filing

Michael HeltzenNamed on SEC filing

Board

George BonarosBoard director

Paul GrintBoard director

Toby RichardsonBoard director

Chris Yoo inBoard MemberGeneral Partner at Xcellerant Ventures

Investors · 3

BioBritLa Jolla

Serra VenturesChampaign · $5M

Suncoast VenturesWalnut Creek

Reported raises · per SEC filings

Form D private placements

$4.8M disclosed across 2 rounds · 2022–2024

▶$3.9MraisedApr 2025 · 14 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Ross BundyExecutive Officer, Director
George BonarosDirector
Paul GrintDirector
Kiana AranDirector
Toby RichardsonDirector
Chris YooDirector

Offering amount: $10M
Amount sold: $3.9M
Minimum investment: $5K
First sale: Jan 2024
Incorporated: Corporation, Delaware, 2021
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$885KraisedMar 2022 · 7 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Michael HeltzenDirector
Ross Helgren BundyExecutive Officer
Kiana AranDirector

Offering amount: $4M
Amount sold: $885K
First sale: Mar 2022
Incorporated: Corporation, Delaware, 2021
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Synthego10 shared keywordsSynthego develops CRISPR gene-editing and molecular diagnostics products, including custom CRISPR editors in mRNA or protein formats, base editors, and cell-free protein and RNA production systems. It serves researchers and cell and gene therapy developers in the biotechnology industry.

CRISPR9 shared keywordsCRISPR Therapeutics is a biotechnology company developing gene-based medicines using CRISPR/Cas9 gene-editing technology. It is led by a management team, board of directors, and scientific founders from the biotech and pharmaceutical industries.

Oup4 shared keywordsOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.

Companies competing with Crisprqc for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Crisprqc do?: CRISPR QC develops the CRISPR Analytics Platform, a graphene-based biosensor system that provides real-time quantitative kinetic measurements of RNP formation, DNA target binding, and CRISPR-Cas cleavage activity. It serves gene-editing discovery, development, and manufacturing teams to pre-screen gRNA efficiency and de-risk experiments before costly downstream sequencing and screening.
Who are Crisprqc's investors?: Crisprqc's investors include BioBrit, Serra Ventures, Suncoast Ventures.
How much funding has Crisprqc raised?: Crisprqc has disclosed $4.8M raised across 2 rounds.
Where is Crisprqc headquartered?: Crisprqc is headquartered in San Diego, US.